Precurarization with Rocuronium Prevents Succinylcholine induced Hyperkalemia by Farhat, Kulsoom
Journal of Rawalpindi Medical College (JRMC); 2012;16(2):141-143 
 
 141 
Original Article  
Precurarization with Rocuronium Prevents 
Succinylcholine induced Hyperkalemia 
Kulsoom Farhat*, Akbar Waheed*, Anwar Kamal Pasha** 
*Department of Pharmacology, Army Medical College, Rawalpindi;**Combined Military Hospital, Rawalpindi. 
Abstract 
Background: To assess the effects of Rocuronium 
pretreatment on Succinylcholine induced rise in serum 
potassium. 
Methods: In this randomized controlled experimental  
study, sixty adults ASA I or II patients who presented for 
elective general surgical procedures were included. The 
patients were divided in two groups of thirty each by a 
simple randomization. Group "A" received succinylcholine 
and group "B" received precurarization dose of rocuronium 
followed by succinylcholine for intubation. Venous blood 
samples were obtained for estimation of serum potassium 
(K+) at 0 minutes and after five minutes of intubation.  
Results: There was a significant rise in serum K+ level 
from the start of the study to five minutes in group A (p < 
0.001). In group B, increase in serum K+ level from start of 
the study to five minutes was significant (p = 0.001) but it 
remained within the normal range. The increase in serum 
K+ level was significantly more in group A as compared to 
group B (p < 0.001). 
 Conclusion: Pretreatment with rocuronium prevents 
the rise in serum potassium induced by succinylcholine. 
Key words:  Succinylcholine, Rocuronium, Potassium, 
Precurarization 
Introduction 
      Succinylcholine is commonly used for muscle 
relaxation at the time of endotracheal intubation. It is a 
depolarizing muscle relaxant, producing  profound 
neuromuscular block with rapid onset but short 
duration. Its short half life becomes life saving in the 
event of difficult intubation or failed intubation. 
Succinylcholine produces many undesired side effects 
such as muscle fasciculations, post operative myalgias, 
increased serum levels of creatinine kinase (CK) and 
K+, succinyl apnea, malignant hyperthermia, raised 
intraocular pressure and intracranial pressure. The 
administration of succinylcholine in humans results in 
a mild and transient hyperkalemia. In normal 
individuals, the increase in serum K+ is approximately 
0.5–1.0 mEq/L, occurs within 3–5 minutes after the IV 
administration of succinylcholine, and lasts less than 
10–15 minutes. However, in certain conditions, such as 
trauma, burns, infection, and certain neuromuscular 
disorders, there is an exaggerated increase in the 
serum K+ level that may manifest clinically in cardiac 
dysrrhythmias and even cardiac arrest. It is related to 
proliferation of extrajunctional cholinergic receptors 
providing more sites for K+ to leak outward from cells 
during depolarization. Severe hyperkalemia after 
succinylcholine resulting in cardiac arrest has also 
been observed in acidotic hypovolemic patients.1-3 
       To minimize the hyperkalemia associated with 
succinylcholine administration, investigators have 
tried pretreatment with various drugs, including 
nondepolarizing neuromuscular relaxants, 
flunitrazepam, diazepam, and magnesium sulfate with 
mixed results . Administration of non depolarizing 
neuromuscular blocker before administration of 
succinylcholine is effective in reducing the increase in 
serum K+ concentration. Pretreatment with a 
nondepolarizing neuromuscular relaxant or diazepam 
to minimize succinylcholine-induced hyperkalemia 
may also be considered in the clinical setting. 5    
    Rocuronium bromide, a new non-depolarizing 
aminosteroidal muscle relaxant is a derivative of 
Vecuronium. It has a more rapid onset of action 
compared with established non-depolarizing agents 
and has an intermediate duration of action (20 – 35 
min)  similar to that of vecuronium and atracurium. 
There is rapid recovery with cardiovascular stability 
and no significant histamine release. Hepato-biliary 
mechanisms primarily account for its elimination. 
Precurarization with this steroidal compound with 
stable cardiovascular profile can thus significantly 
decrease the side effects of succinylcholine and can  
maximize  patients satisfaction after succinylcholine is 
used. It is both safe and effective provided the dose 
does not exceed 10% of the ED95.6-9  
 
Patients and Methods 
   This single blind, randomized, case control study 
was conducted in department of Anaesthesia, 
Combined Military Hospital, Rawalpindi. Sixty 
patients were allocated randomly in two groups. 
Patients in group "A" received succinylcholine and 
patients in group "B" received rocuronium for 
precurarization followed by succinylcholine.Both 
groups were comparable in respect to age, sex and 
Journal of Rawalpindi Medical College (JRMC); 2012;16(2):141-143 
 
 142 
weight and undergoing general surgical procedures. 
Patients with no proper medical history, intraocular 
hypertension, history of malignant hyperthermia, ASA 
status III and above, Diabetes mellitus, morbidly 
obese, pregnant patients and suspected difficult 
intubation patients were excluded 
      Standard anaesthesia technique was employed in 
all patients. Direct laryngoscopy was performed and 
the patients were intubated via oral route, 60 seconds 
after succinylcholine. Anaesthesia was maintained by 
67% nitrous oxide and 1% halothane in oxygen. The 
blood samples were collected at 0 minutes before 
induction of anesthesia and 05 minutes after giving the 
drug for intubation. The estimation of serum K+ was 
done by ion selective electrode method.  Descriptive 
statistics were used to describe the data. Mean and 
standard error of mean (S.E.M) were used to describe 
quantitative variables like age, weight and K+. Paired 
sample t-test was used to compare initial and final 
values of K+ within the groups. Chi-square test was 
used to compare qualitative variables between the 
groups . p value < 0.05 was considered as significant. 
Results 
    The mean age of Group A patients was 39.97 ± 1.833 
years (range 18-65 years) and of Group B was 36.63+ 
1.791 (range 18- 65 years). At the start of the study (at 0 
hours), in group A average serum K+ level (+ S.E.M) 
was 4.09 (+ 0.071) millimole per litre (mmol/L) and in 
group B it was 4.08 + 0.072 mmol/L. There was 
insignificant difference between the groups (p = 0.744) 
(Table 1).  
Table 1: Initial and final levels of serum 
potassium (K+) in the groups 
 Group A(n= 30) Group B(n= 30) 
At 0 hrs 4.09 ±0.071mmol/l 4.08 ± 0.072mmol/l 
After 5 
min 
4.90 ±0.141*mmol/l 4.32 ± 0.074*mmol/L 
            NS : Not Significant;    *  p  value < 0.05 
 
      After five minutes of administration of the drug for 
intubation, average serum K+ level in group A was 
4.90 + 0.0141 mmol/L. In group A, increase in serum 
K+ level from the start of the study to five minutes was 
significant (p < 0.001) (Table 1). In group B average 
serum K+ level at five minutes was 4.32 + 0.074 
mmol/L. Increase in serum K+ level from start of the 
study to five minutes was significant (p = 0.001) but 
the values remained within the normal range (Table 1). 
Average increase in serum K+ level or the difference of 
the mean in group A was 0.810 + 0.106 mmol/L and in 
group B it was 0.243 + 0.062 mmol/L (Table 2). The 
increase in serum K+ level was significantly more in 
group A as compared to group B (p < 0.001) (p < 0.001) 
(Table 3). 
Table 2: Comparison of change in serum 
potassium (K+) level between the groups 
Groups Difference of 
Mean 
S.E.M 
Group A (n = 30) 0.810 0.106 
Group B (n = 30) 0.243 0.062 
p value < 0.001 
     
Table 3: Comparison of serum potassium 
(K+) between group A and group B 
 Group A(n= 30) Group B(n= 30) 
At 0 hours 4.09 ± .071mmol/L(NS) 4.08 
0.072mmol/l 
(NS) 
After five 
minutes 
4.90 ± 0.141*mmol/l 4.32 ± 
0.074*mmol/l 
Difference  
Mean + S.E.M 
+0.810 + 0.106 +0.243 +  0.062 
NS:    Not Significant; *  p  < 0.05;  S.E.M     Standard Error of Mean;   
   +         An increase in the average after five minutes 
Discussion 
     Succinylcholine  is associated with muscular injury 
as it depolarizes the muscles prior to paralysis. This 
muscular injury is manifested in the form of 
fasciculations, myalgia and increased muscle enzymes 
like CK in the serum. Moreover, the subsequent rise in 
serum K+ as a result of its depolarizing mechanism of 
action can clinically manifest as cardiac arrest in the 
susceptible individuals .These muscular unwanted 
effects of succinylcholine have limited its usefulness 
and present distressing consequences for the patients 
after minor surgeries. On the other hand the 
nondepolarizing muscle relaxant rocuronium 
circumvents most of these adverse effects but the high 
cost and the universal non availability makes it less of 
a choice for intubation.10-13 
    There is a rise in serum K+ after injection of 
succinylcholine especially in patients with certain 
conditions like burns, neuromuscular disease, closed 
head injury, intra-abdominal infection and renal 
failure. The repeated doses of succinylcholine in 
patients with renal failure are probably best avoided. 
If administration of repeated doses is contemplated, 
pretreatment with glycopyrrolate or atropine to 
protect against succinylcholine-induced bradycardia 
should be considered. A high preoperative 
concentration of serum K+ seems to be associated with 
a much higher probability of cardiac arrest following 
administration of succinylcholine . This rise , in K+ is 
presumed to be due to ionic flux from muscles in 
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association with period of depolarization. With the 
administration of succinylcholine and the 
depolarization of the muscle membrane, the resultant 
fasciculations cause the release of K+ into the 
circulation. It has been observed that this rise in 
plasma K+ is greater in those patients who experience 
postoperative myalgia than in those who do not suffer 
from this untoward effect. 14-15 
     The efficacy of precurarization to prevent rise in 
serum K+ is recognized in a very few studies. d-
tubocurarine 0.1 mg/kg  has been shown to limit the 
extent of succinylcholine-induced hyperkalemia in 
digitalized and traumatized patients but not in normal 
patients. It was  found that pretreatment with d-
tubocurarine did not prevent a moderate increase in 
serum K+ after succinylcholine administration in 
normal patients and those with renal failure. 
Pretreatment with a nondepolarizing agent,like 
rocutonium,may be considered in a clinical setting to 
minimize succinylcholine-induced hyperkalemia. 16,17  
      High cost of rocuronuium is a limitation. The cost 
of this drug in the market presently is eleven times 
more than that of succinylcholine. As an intubating 
drug, it is not used routinely and it would therefore be 
unfair to use the drug without documented evidence 
of the benefit of this technique. 18,19  
 
Conclusions 
 1.Precurarization will decrease the succinylcholine-
induced hyperkalemia on one hand and on the other  
will minimize cost of intubation.  
2.Precurazation will decrease the cardiac adverse 
effects improving the side effect profile of the most 
commonly used and  cost effective neuromuscular 
blocking agents 
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